The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of TST001, a high affinity humanized anti-CLDN18.2 monoclonal antibody, in combination with capecitabine and oxaliplatin (CAPOX) as a first-line treatment of advanced G/GEJ cancer.
 
Jifang Gong
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Weijian Guo
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Hongli Li
No Relationships to Disclose
 
Fuyou Zhao
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Meili Sun
Speakers' Bureau - TopAlliance BioSciences Inc
 
Zhenzhong Xia
Employment - Ascentage Pharma Group; MabSpace Biosciences
 
Yu Shen
No Relationships to Disclose
 
Jianming Wang
No Relationships to Disclose
 
Lingmin Lu
No Relationships to Disclose
 
Chuan Qi
No Relationships to Disclose
 
Xueming Qian
Employment - Transcenta
Leadership - Transcenta
Stock and Other Ownership Interests - Transcenta
 
Michael Shi
Employment - Transcenta
Leadership - Transcenta
Stock and Other Ownership Interests - Transcenta
Patents, Royalties, Other Intellectual Property - Multiple patents in oncology field at Novartis. Assign rights to Novartis
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche
Speakers' Bureau - Hutchison Whampoa; MSD
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)